Unaudited Q3 and nine-month results released; 912,500 ESOPs approved at ₹1,344.97 exercise price, vesting over four years with 36-month exercise window. Regulatory disclosures accompanying the results provided.
AI Assistant
CreditAccess Grameen Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.